Skip to main content Back to Top
Advertisement

3/21/2022

Sertraline Oral Tablets

Products Affected - Description

    • Sertraline oral tablet, Accord, 25 mg, bottle, 30 count, NDC 16729-0215-10 - discontinued
    • Sertraline oral tablet, Exelan Pharmaceuticals, 100 mg, bottle, 90 count, NDC 76282-0214-90
    • Sertraline oral tablet, Exelan Pharmaceuticals, 100 mg, bottle, 100 count, NDC 76282-0214-01
    • Sertraline oral tablet, Greenstone, 100 mg, bottle, 30 count, NDC 59762-5160-01 - discontinued
    • Sertraline oral tablet, Greenstone, 100 mg, bottle, 100 count, NDC 59762-5160-02 - discontinued
    • Sertraline oral tablet, Greenstone, 100 mg, bottle, 500 count, NDC 59762-5160-03 - discontinued
    • Sertraline oral tablet, Greenstone, 25 mg, bottle, 30 count, NDC 59762-6347-01 - discontinued
    • Sertraline oral tablet, Greenstone, 50 mg, bottle, 30 count, NDC 59762-6443-01 - discontinued
    • Sertraline oral tablet, Greenstone, 50 mg, bottle, 100 count, NDC 59762-6443-02 - discontinued
    • Sertraline oral tablet, Greenstone, 50 mg, bottle, 500 count, NDC 59762-6443-03 - discontinued

Reason for the Shortage

    • Accord has sertraline tablets available.
    • Aurobindo refuses to provide availability information.
    • Cipla USA has sertraline tablets available.
    • Exelan Pharmaceuticals has most presentations available.
    • Greenstone discontinued sertraline tablets in October 2021.
    • Lupin has sertraline tablets available.
    • Pfizer has Zoloft available.

Available Products

    • Zoloft oral tablet, Pfizer, 100 mg, bottle, 30 count, NDC 00049-4910-30
    • Zoloft oral tablet, Pfizer, 100 mg, unit-dose blister pack, 10 count, NDC 00049-4910-41
    • Zoloft oral tablet, Pfizer, 25 mg, bottle, 30 count, NDC 00049-4960-30
    • Zoloft oral tablet, Pfizer, 50 mg, bottle, 100 count, NDC 00049-4900-41
    • Zoloft oral tablet, Pfizer, 50 mg, unit-dose blister pack, 10 count, NDC 00049-4900-30
    • Sertraline oral tablet, Accord, 100 mg, bottle, 90 count, NDC 16729-0217-15
    • Sertraline oral tablet, Accord, 100 mg, bottle, 500 count, NDC 16729-0217-16
    • Sertraline oral tablet, Accord, 25 mg, bottle, 90 count, NDC 16729-0215-15
    • Sertraline oral tablet, Accord, 25 mg, bottle, 500 count, NDC 16729-0215-16
    • Sertraline oral tablet, Accord, 50 mg, bottle, 90 count, NDC 16729-0216-15
    • Sertraline oral tablet, Accord, 50 mg, bottle, 500 count, NDC 16729-0216-16
    • Sertraline oral tablet, Cipla USA, 100 mg, bottle, 30 count, NDC 69097-0835-02
    • Sertraline oral tablet, Cipla USA, 100 mg, bottle, 500 count, NDC 69097-0835-12
    • Sertraline oral tablet, Cipla USA, 25 mg, bottle, 30 count, NDC 69097-0833-02
    • Sertraline oral tablet, Cipla USA, 25 mg, bottle, 90 count, NDC 69097-0833-05
    • Sertraline oral tablet, Cipla USA, 25 mg, bottle, 500 count, NDC 69097-0833-12
    • Sertraline oral tablet, Cipla USA, 50 mg, bottle, 30 count, NDC 69097-0834-02
    • Sertraline oral tablet, Cipla USA, 50 mg, bottle, 500 count, NDC 69097-0834-12
    • Sertraline oral tablet, Exelan Pharmaceuticals, 100 mg, bottle, 30 count, NDC 76282-0214-30
    • Sertraline oral tablet, Exelan Pharmaceuticals, 100 mg, bottle, 60 count, NDC 76282-0214-60
    • Sertraline oral tablet, Exelan Pharmaceuticals, 100 mg, bottle, 180 count, NDC 76282-0214-18
    • Sertraline oral tablet, Exelan Pharmaceuticals, 100 mg, bottle, 500 count, NDC 76282-0214-05
    • Sertraline oral tablet, Exelan Pharmaceuticals, 25 mg, bottle, 30 count, NDC 76282-0212-30
    • Sertraline oral tablet, Exelan Pharmaceuticals, 25 mg, bottle, 60 count, NDC 76282-0212-60
    • Sertraline oral tablet, Exelan Pharmaceuticals, 25 mg, bottle, 90 count, NDC 76282-0212-90
    • Sertraline oral tablet, Exelan Pharmaceuticals, 25 mg, bottle, 100 count, NDC 76282-0212-01
    • Sertraline oral tablet, Exelan Pharmaceuticals, 25 mg, bottle, 180 count, NDC 76282-0212-18
    • Sertraline oral tablet, Exelan Pharmaceuticals, 25 mg, bottle, 500 count, NDC 76282-0212-05
    • Sertraline oral tablet, Exelan Pharmaceuticals, 50 mg, bottle, 30 count, NDC 76282-0213-30
    • Sertraline oral tablet, Exelan Pharmaceuticals, 50 mg, bottle, 60 count, NDC 76282-0213-60
    • Sertraline oral tablet, Exelan Pharmaceuticals, 50 mg, bottle, 90 count, NDC 76282-0213-90
    • Sertraline oral tablet, Exelan Pharmaceuticals, 50 mg, bottle, 100 count, NDC 76282-0213-01
    • Sertraline oral tablet, Exelan Pharmaceuticals, 50 mg, bottle, 180 count, NDC 76282-0213-18
    • Sertraline oral tablet, Exelan Pharmaceuticals, 50 mg, bottle, 500 count, NDC 76282-0213-05
    • Sertraline oral tablet, Lupin, 100 mg, bottle, 30 count, NDC 68180-0353-06
    • Sertraline oral tablet, Lupin, 100 mg, bottle, 90 count, NDC 68180-0353-09
    • Sertraline oral tablet, Lupin, 100 mg, bottle, 500 count, NDC 68180-0353-02
    • Sertraline oral tablet, Lupin, 100 mg, bottle, 5000 count, NDC 68180-0353-05
    • Sertraline oral tablet, Lupin, 25 mg, bottle, 30 count, NDC 68180-0351-06
    • Sertraline oral tablet, Lupin, 25 mg, bottle, 90 count, NDC 68180-0351-09
    • Sertraline oral tablet, Lupin, 25 mg, bottle, 1000 count, NDC 68180-0351-03
    • Sertraline oral tablet, Lupin, 50 mg, bottle, 30 count, NDC 68180-0352-06
    • Sertraline oral tablet, Lupin, 50 mg, bottle, 90 count, NDC 68180-0352-09
    • Sertraline oral tablet, Lupin, 50 mg, bottle, 500 count, NDC 68180-0352-02
    • Sertraline oral tablet, Lupin, 50 mg, bottle, 5000 count, NDC 68180-0352-05

Updated

Updated March 21, 2022 by Leslie Jensen, PharmD, Drug Information Specialist. Created May 18, 2020 by Anthony Trovato, PharmD, BCPS. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.
ADVERTISEMENT